CS
RETA

Comerica Securities’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Comerica Securities’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15
Closed -$570 – 1488
2022
Q4 		$570 Buy
+15
New +$570 ﹤0.01% 1409